16 Jul 2018

APPLE UPDATES APP ALLOWING PATIENTS TO SEE HEALTH RECORDS ON THEIR IPHONE

  Apple has updated the Health app with the iOS 11.3 beta, debuting a feature for customers to see their medical records right on their iPhone. The updated Health Records section within the Health app brings together hospitals, clinics and the existing Health app to make it easy for consumers

0
16 Jul 2018

STUDY SHOWS RESULTS CHANGING WHITE FAT INTO BROWN FAT FOR EASIER WEIGHT LOSS

Obesity results from excess white fat storage, making it difficult to treat because the effectiveness of diet, exercise, and systemic anti-obesity agents is limited, and in the latter case may cause serious side effects. As a result, researchers are investigating innovative strategies for localized delivery of fat burning compounds via

0
16 Jul 2018

WHY IS IT STILL TAKING SO LONG TO BUILD A STUDY?

  By Nick O’Brien The Tufts Center for the Study of Drug Development released its 2017 eClinical Landscape Study (outsourcing-pharma.com/Article/2017/10/12/Clinical-trial-database-tribulations-stunt-trial-timelines) late last year, and among the results is a troubling statistic. Companies conducting clinical trials are taking an average of 68 days to build their studies, with 77 percent of survey respondents

0
16 Jul 2018

AVINGER RECEIVES FDA CLEARANCE FOR PANTHERIS DEVICE; SHARES AHEAD 47% PREMARKET

Avinger has received 510(k) clearance from the FDA for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease (P.A.D.). Lumivascular is the only technology that combines real-time intravascular imaging with highly effective catheters for the treatment of P.A.D. The Company intends to launch two versions

0
26 Jun 2018

BRITISH COLUMBIA RESEARCHERS PRODUCE FIRST ANGIOPLASTY-READY SMART STENT

Vascular stents are some of the most commonly implanted medical devices, keeping millions of arteries open to uninterrupted blood flow. Though they tend to work well at first, too many end up being re-stenosed by new deposits of plaque and scar tissue often forms in the vicinity, blocking blood flow

0
26 Jun 2018

VENA CAVA FILTERS TO SEE DOUBLE-DIGIT CAGR ANNUAL GROWTH

The global inferior vena cava filters (IVCFs)market is expected to grow at a compounded annual growth rate (CAGR) of more than 11 percent during the period 2018-2022, according to a new 126-page market research study (SKU: IRTNTR21662) published early this year by Technavio. A free sample report or the full

0
24 Jun 2018

INTACT VASCULAR OFFERS TOBA BTK DATA

Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, has praised the publication of the Tack Optimized Balloon Angioplasty Below the Knee (TOBA BTK) clinical trial results in the current issue of Catheterization and Cardiovascular Intervention. This multi-center pilot study focused on collecting data supporting

0
07 Jun 2018

OPTALYSE PE: BTG RESULTS REINFORCE SAFETY, EFFICACY OF SHORTER, LOWER DOSE EKOS THERAPY FOR PE

BTG plc highlighted OPTALYSE PE one-year trial results, presented at the International Society on Endovascular Therapy in Florida in February. The findings confirm that bilateral pulmonary embolism (PE) patients treated in as little as two hours with a total tissue plasminogen activator (tPA) dose as low as 8mg continue to

0
03 Apr 2018

BTG OPTALYSE PE TRIAL RESULTS REINFORCE SAFETY AND EFFICACY OF SHORTER, LOWER DOSE EKOS THERAPY FOR PE

BTG plc highlighted OPTALYSE PE one-year trial results, presented at the International Society on Endovascular Therapy in Florida in February. The findings confirm that bilateral pulmonary embolism (PE) patients treated in as little as two hours with a total tissue plasminogen activator (tPA) dose as low as 8mg continue to

0